GR3006598T3 - - Google Patents

Info

Publication number
GR3006598T3
GR3006598T3 GR920403006T GR920403006T GR3006598T3 GR 3006598 T3 GR3006598 T3 GR 3006598T3 GR 920403006 T GR920403006 T GR 920403006T GR 920403006 T GR920403006 T GR 920403006T GR 3006598 T3 GR3006598 T3 GR 3006598T3
Authority
GR
Greece
Prior art keywords
combination
diabetic
conditions
phatological
hemodialyses
Prior art date
Application number
GR920403006T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3006598T3 publication Critical patent/GR3006598T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GR920403006T 1988-08-12 1992-12-21 GR3006598T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8810886A FR2635264B1 (fr) 1988-08-12 1988-08-12 Compositions pharmaceutiques et/ou dietetiques contenant de la l-carnitine et de la l-lysine

Publications (1)

Publication Number Publication Date
GR3006598T3 true GR3006598T3 (el) 1993-06-30

Family

ID=9369324

Family Applications (2)

Application Number Title Priority Date Filing Date
GR90300149T GR900300149T1 (en) 1988-08-12 1991-09-27 Pharmaceutical and/or dietetical compositions containing l-carnitine and l-lysine
GR920403006T GR3006598T3 (el) 1988-08-12 1992-12-21

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GR90300149T GR900300149T1 (en) 1988-08-12 1991-09-27 Pharmaceutical and/or dietetical compositions containing l-carnitine and l-lysine

Country Status (10)

Country Link
EP (2) EP0428608A1 (el)
JP (1) JP2785989B2 (el)
AT (1) ATE82122T1 (el)
CA (1) CA1341260C (el)
DE (2) DE354848T1 (el)
ES (1) ES2043062T3 (el)
FR (1) FR2635264B1 (el)
GR (2) GR900300149T1 (el)
PT (1) PT91430B (el)
WO (1) WO1990001316A1 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2660557B1 (fr) * 1990-04-09 1994-05-27 Endobio Groupe Etu Rech Risqu Compositions pharmaceutiques et/ou dietetiques contenant de la carnitine, de la lysine et de la methionine avec ou sans acide pantothenique.
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
IT1306147B1 (it) * 1999-05-28 2001-05-30 Biosalts Srl Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali
IT1306186B1 (it) 1999-09-03 2001-05-30 Biosalts Srl Sali non igroscopici di principi attivi ad attivita' terapeutica e/onutrizionale e composizioni atte alla somministrazione orale
IT1317042B1 (it) * 2000-06-14 2003-05-26 Biosalts Srl Fumarati doppi di una carnitina e creatina, e integratori alimentari,dietetici e farmaci che li contengono.
WO2017002718A1 (ja) * 2015-07-01 2017-01-05 株式会社明治 継粉形成抑制剤
CA3061158A1 (en) * 2017-04-25 2018-11-01 Almeda Labs Llc Amino acid formulations for pancreatic viability

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4465M (el) * 1965-06-28 1966-09-26
FR2119882A1 (en) 1970-12-31 1972-08-11 Prugnaud Robert Calcium hypophosphite-ascorbate/carnitine compsn - used as appetite stimulant
US3830931A (en) * 1972-11-06 1974-08-20 Felice S De Carnitine and its use in the treatment of arrhythmia and impaired cardiac function
US3968241A (en) * 1972-11-06 1976-07-06 Defelice Stephen L Method of treating cardiac arrhythmias and of improving myocardial contractility and systolic rhythm with carnitive or a pharmaceutically acceptable salt thereof
IT1120033B (it) * 1979-10-05 1986-03-19 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion

Also Published As

Publication number Publication date
JPH04500073A (ja) 1992-01-09
FR2635264A1 (fr) 1990-02-16
PT91430B (pt) 1995-05-31
GR900300149T1 (en) 1991-09-27
EP0354848B1 (fr) 1992-11-11
ATE82122T1 (de) 1992-11-15
DE68903448D1 (de) 1992-12-17
DE354848T1 (de) 1992-05-21
CA1341260C (fr) 2001-06-19
JP2785989B2 (ja) 1998-08-13
PT91430A (pt) 1990-03-08
ES2043062T3 (es) 1993-12-16
WO1990001316A1 (fr) 1990-02-22
FR2635264B1 (fr) 1992-02-28
DE68903448T2 (de) 1993-03-18
EP0428608A1 (fr) 1991-05-29
EP0354848A1 (fr) 1990-02-14

Similar Documents

Publication Publication Date Title
US5091171B2 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
PT614616E (pt) Composicao para o tratamento de pacientes com doenca hepatica
PT787489E (pt) Composicao contendo propionil-l-carnitina e acido hidroxicitrico ou acido pantotenico
KR840003414A (ko) 3-히드록시부탄산 또는 이 산으로부터 유도된 염을 함유하는 약학적 조성물과, 의약품으로 사용할 수 있는 3-히드록시부탄산으로부터 유도된 화합물
ATE79748T1 (de) Viruzides mittel mit breitbandwirkung.
PT1216041E (pt) Dieta com elevado teor de lipidos
ES8106513A1 (es) Procedimiento para la preparacion de sales de la (+)-cate- quina
DE69302883T2 (de) L-Carnitin- und Alkanoyl-L-Carnitin-Ester mit Glykolsäure oder ihre Ester und diese enthaltende pharmazeutische Zusammensetzungen zur Behandlung von Dermatosen
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
EP0586235A3 (el)
GR3006598T3 (el)
AU652785B2 (en) Nutrition
PT95212A (pt) Processo para a preparacao de uma composicao para uso topico para o tratamento da fragilidade capilar, contendo defibrotide
ATE22804T1 (de) Pharmazeutische zusammensetzung.
FI934082A (fi) Kitosanbaserade naerings- och laekemedelskompositioner foer idisslare
NO870941L (no) Vandige preparater med fytotoksisk virkning.
LU81501A1 (fr) Compositions pharmaceutiques comprenant de la trimethoprime,ainsi que des derives d'acides n-ethyl-gamma-pyridone-3-carboxyliques
MX9204423A (es) Medicamento que contiene antagonistas de calcio y procedimiento para su fabricacion.
GT198500020A (es) 1,4-dihidropiridinlactonas 1-alquil-sustituidas, procedimiento para su obtencion y su empleo en medicamentos.
JPS5270027A (en) Herbicidal action promoter